Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
12.26
+0.10 (0.82%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CATX stock have an average target of 21.33, with a low estimate of 17 and a high estimate of 27. The average target predicts an increase of 73.98% from the current stock price of 12.26.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CATX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 4 |
| Buy | 1 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 5 | 5 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +71.29% | Sep 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 3, 2024 |
Financial Forecast
Revenue This Year
1.22M
from 1.43M
Decreased by -15.13%
Revenue Next Year
762.14K
from 1.22M
Decreased by -37.38%
EPS This Year
-0.89
from -1.74
EPS Next Year
-1.03
from -0.89
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.0M | 2.1M | 2.2M | |
| Avg | 1.2M | 762,144 | 592,875 | |
| Low | 833,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 41.7% | 73.6% | 188.4% | |
| Avg | -15.1% | -37.4% | -22.2% | |
| Low | -41.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.81 | -0.75 | -0.78 |
| Avg | -0.89 | -1.03 | -1.13 |
| Low | -0.93 | -1.25 | -1.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.